| Overview |
| bsm-90360R |
| Amyloid beta precursor protein Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Amyloid beta A4 |
| 700-770/770 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 351 |
| P05067 |
| APP; Amyloid Beta Precursor Protein; Alpha-SAPP; AD1; Alzheimer Disease Amyloid A4 Protein Homolog; Amyloid Beta (A4) Precursor Protein; Alzheimer Disease Amyloid Protein; Cerebral Vascular Amyloid Peptide; Amyloid-Beta Precursor Protein; Amyloid Precursor Protein; Peptidase Nexin-II; Protease Nexin-II; PN-II; PreA4; ABPP; APPI; CVAP; Amyloid-Beta (A4) Precursor Protein; Beta-Amyloid Precursor Protein; Testicular Tissue Protein Li; Beta-Amyloid Peptide(1-40); Beta-Amyloid Peptide(1-42); Amyloid Beta A4 Protein; Amyloid-Beta A4 Protein; Beta-Amyloid Peptide; Alzheimer Disease; CTFgamma; ABETA; AAA; PN2; A4 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz